{"organizations": [], "uuid": "3a642af9e18125b69a3782d31d443e4e11665244", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/drreddys-results/indias-dr-reddys-q4-profit-falls-3-pct-misses-estimates-idUSL3N1ST2SB", "country": "US", "domain_rank": 408, "title": "India's Dr. Reddy's Q4 profit falls 3 pct, misses estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-22T10:47:00.000+03:00", "replies_count": 0, "uuid": "3a642af9e18125b69a3782d31d443e4e11665244"}, "author": "", "url": "https://www.reuters.com/article/drreddys-results/indias-dr-reddys-q4-profit-falls-3-pct-misses-estimates-idUSL3N1ST2SB", "ord_in_thread": 0, "title": "India's Dr. Reddy's Q4 profit falls 3 pct, misses estimates", "locations": [], "entities": {"persons": [{"name": "reddy", "sentiment": "negative"}, {"name": "biju dwarakanath", "sentiment": "none"}, {"name": "arnab paul", "sentiment": "none"}], "locations": [{"name": "india", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "laboratories ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 22, 2018 / 7:49 AM / Updated 10 minutes ago CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates Reuters Staff 1 Min Read\n(Corrects all figures except analysts’ estimates to reflect figures as per Indian Accounting Standard Rules)\nMay 22 (Reuters) - Indian generic drugmaker Dr. Reddy’s Laboratories Ltd posted an about 19 percent fall in quarterly net profit, missing estimates, hurt by headwinds in the U.S. market.\nProfit for the quarter ended March 31 came in at 2.72 billion rupees ($39.98 million) versus 3.38 billion rupees a year earlier, the company said here\nAnalysts on average estimated a profit of 3.59 billion rupees, according to Thomson Reuters data.\nNet sales fell slightly to 34.46 billion rupees. ($1 = 68.0400 Indian rupees) (Reporting by Arnab Paul in Bengaluru; Editing by Biju Dwarakanath)", "external_links": ["https://www.bseindia.com/xml-data/corpfiling/AttachLive/280bdd33-dda4-4c5f-8624-b01b7efaeb68.pdf."], "published": "2018-05-22T10:47:00.000+03:00", "crawled": "2018-05-22T10:56:33.074+03:00", "highlightTitle": ""}